comparemela.com
Home
Live Updates
Simon Hinsley - Breaking News
Pages:
10
11
12
13
14
15
16
Latest Breaking News On - Simon hinsley - Page 9 : comparemela.com
Dubber wins The RegTech Association 2021 RegTech of the Year Award
/PRNewswire/ Dubber Corporation Limited (ASX: DUB) today announced that the RegTech Association has awarded Dubber the 2021 RegTech of the Year.
United states
Terry alberstein
Asia pacific
James slaney
Simon hinsley
Service provider
Regtech association
Dubber corporation limited
Service providers
Its software
Webex calling
Microsoft teams
Unified conversational recording
Call recording
Unified call recording
Voice intelligence cloud
Dubber wins The RegTech Association 2021 RegTech of the Year Award
/PRNewswire/ Dubber Corporation Limited (ASX: DUB) today announced that the RegTech Association has awarded Dubber the 2021 RegTech of the Year.
United states
Terry alberstein
Asia pacific
James slaney
Simon hinsley
Service provider
Regtech association
Dubber corporation limited
Service providers
Its software
Webex calling
Microsoft teams
Unified conversational recording
Call recording
Unified call recording
Voice intelligence cloud
Fifty percent recruitment milestone for PROPELLER prostate cancer trial
/PRNewswire/ Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the.
United states
Alan taylor
Simon hinsley
National cancer institute
Clarity pharmaceuticals
Technology platform
Cancer statistics center
American cancer society
Executive chairman
Phasei positron emission tomography
Louise emmett
Hospital sydney
Principal investigator
Targeted copper theranostics
Cancer statistics
Mortality worldwide
Fifty percent recruitment milestone for PROPELLER prostate cancer trial
SYDNEY, Dec. 1, 2021 /PRNewswire/ — Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the.
United states
New south wales
Alan taylor
Simon hinsley
Clarity pharmaceuticals
National cancer institute
Technology platform
Cancer statistics center
American cancer society
Uptake value
Executive chairman
Phasei positron emission tomography
Louise emmett
Hospital sydney
Principal investigator
Targeted copper theranostics
Fifty percent recruitment milestone for PROPELLER prostate cancer trial
/PRNewswire/ Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the.
United states
Alan taylor
Simon hinsley
National cancer institute
Clarity pharmaceuticals
Technology platform
Cancer statistics center
American cancer society
Executive chairman
Phasei positron emission tomography
Louise emmett
Hospital sydney
Principal investigator
Targeted copper theranostics
Cancer statistics
Mortality worldwide
vimarsana © 2020. All Rights Reserved.